|
1
|
Ankö ML and Neugebauer KM: Long non-coding
RNAs add another layer to pre-mRNA splicing regulation. Mol Cell.
39:833–834. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rottiers V and Näär AM: MicroRNAs in
metabolism and metabolic disorders. Nat Rev Mol Cell Biol.
13:239–250. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Stefani G and Slack FJ: Small non-coding
RNAs in animal development. Nat Rev Mol Cell Biol. 9:219–230. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Li J, Meng H, Bai Y and Wang K: Regulation
of lncRNA and its role in cancer metastasis. Oncol Res. 23:205–217.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Dhamija S and Diederichs S: From junk to
master regulators of invasion: lncRNA functions in migration, EMT
and metastasis. Int J Cancer. 139:269–280. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Betancur JG: Pervasive lncRNA binding by
epigenetic modifying complexes - The challenges ahead. Biochim
Biophys Acta. 1859:93–101. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Blythe AJ, Fox AH and Bond CS: The ins and
outs of lncRNA structure: How, why and what comes next? Biochim
Biophys Acta. 1859:46–58. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sun M, Nie FQ, Wang ZX and De W:
Involvement of lncRNA dysregulation in gastric cancer. Histol
Histopathol. 31:33–39. 2016.PubMed/NCBI
|
|
9
|
Kaikkonen MU, Lam MT and Glass CK:
Non-coding RNAs as regulators of gene expression and epigenetics.
Cardiovasc Res. 90:430–440. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Rinn JL and Chang HY: Genome regulation by
long non-coding RNAs. Annu Rev Biochem. 81:145–166. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ponting CP, Oliver PL and Reik W:
Evolution and functions of long non-coding RNAs. Cell. 136:629–641.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wilusz JE, Sunwoo H and Spector DL: Long
non-coding RNAs: Functional surprises from the RNA world. Genes
Dev. 23:1494–1504. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ji P, Diederichs S, Wang W, Böing S,
Metzger R, Schneider PM, Tidow N, Brandt B, Buerger H, Bulk E, et
al: MALAT-1, a novel non-coding RNA, and thymosin beta4 predict
metastasis and survival in early-stage non-small cell lung cancer.
Oncogene. 22:8031–8041. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hutchinson JN, Ensminger AW, Clemson CM,
Lynch CR, Lawrence JB and Chess A: A screen for nuclear transcripts
identifies two linked non-coding RNAs associated with SC35 splicing
domains. BMC Genomics. 8:392007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tripathi V, Ellis JD, Shen Z, Song DY, Pan
Q, Watt AT, Freier SM, Bennett CF, Sharma A, Bubulya PA, et al: The
nuclear-retained non-coding RNA MALAT1 regulates alternative
splicing by modulating SR splicing factor phosphorylation. Mol
Cell. 39:925–938. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wilusz JE, Freier SM and Spector DL: 3′
end processing of a long nuclear-retained non-coding RNA yields a
tRNA-like cytoplasmic RNA. Cell. 135:919–932. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ying L, Chen Q, Wang Y, Zhou Z, Huang Y
and Qiu F: Upregulated MALAT-1 contributes to bladder cancer cell
migration by inducing epithelial-to-mesenchymal transition. Mol
Biosyst. 8:2289–2294. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gutschner T, Hämmerle M, Eissmann M, Hsu
J, Kim Y, Hung G, Revenko A, Arun G, Stentrup M, Gross M, et al:
The non-coding RNA MALAT1 is a critical regulator of the metastasis
phenotype of lung cancer cells. Cancer Res. 73:1180–1189. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang SH, Zhang WJ, Wu XC, Zhang MD, Weng
MZ, Zhou D, Wang JD and Quan ZW: Long non-coding RNA Malat1
promotes gallbladder cancer development by acting as a molecular
sponge to regulate miR-206. Oncotarget. 7:37857–37867.
2016.PubMed/NCBI
|
|
20
|
Lai MC, Yang Z, Zhou L, Zhu QQ, Xie HY,
Zhang F, Wu LM, Chen LM and Zheng SS: Long non-coding RNA MALAT-1
overexpression predicts tumor recurrence of hepatocellular
carcinoma after liver transplantation. Med Oncol. 29:1810–1816.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Luo F, Sun B, Li H, Xu Y, Liu Y, Liu X, Lu
L, Li J, Wang Q, Wei S, et al: A MALAT1/HIF-2α feedback loop
contributes to arsenite carcinogenesis. Oncotarget. 7:5769–5787.
2016.PubMed/NCBI
|
|
22
|
Konishi H, Ichikawa D, Yamamoto Y, Arita
T, Shoda K, Hiramoto H, Hamada J, Itoh H, Fujita Y, Komatsu S, et
al: Plasma level of metastasis-associated lung adenocarcinoma
transcript 1 is associated with liver damage and predicts
development of hepatocellular carcinoma. Cancer Sci. 107:149–154.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tripathi V, Shen Z, Chakraborty A, Giri S,
Freier SM, Wu X, Zhang Y, Gorospe M, Prasanth SG, Lal A, et al:
Long non-coding RNA MALAT1 controls cell cycle progression by
regulating the expression of oncogenic transcription factor B-MYB.
PLoS Genet. 9:e10033682013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tano K, Mizuno R, Okada T, Rakwal R,
Shibato J, Masuo Y, Ijiri K and Akimitsu N: MALAT-1 enhances cell
motility of lung adenocarcinoma cells by influencing the expression
of motility-related genes. FEBS Lett. 584:4575–4580. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gutschner T, Hämmerle M and Diederichs S:
MALAT1 - a paradigm for long non-coding RNA function in cancer. J
Mol Med (Berl). 91:791–801. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hansen GM, Markesich DC, Burnett MB, Zhu
Q, Dionne KM, Richter LJ, Finnell RH, Sands AT, Zambrowicz BP and
Abuin A: Large-scale gene trapping in C57BL/6N mouse embryonic stem
cells. Genome Res. 18:1670–1679. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hogan B, Beddington R, Costantini F and
Lacy E: Manipulating the Mouse Embryo: A Laboratory Manual. Cold
Spring Harbor Laboratory Press; New York, NY: 1994
|
|
29
|
Fausto N and Campbell JS: Mouse models of
hepatocellular carcinoma. Semin Liver Dis. 30:87–98. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Miard S, Dombrowski L, Carter S, Boivin L
and Picard F: Aging alters PPARgamma in rodent and human adipose
tissue by modulating the balance in steroid receptor coactivator-1.
Aging Cell. 8:449–459. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Guo F, Li Y, Liu Y, Wang J, Li Y and Li G:
Inhibition of metastasis-associated lung adenocarcinoma transcript
1 in CaSki human cervical cancer cells suppresses cell
proliferation and invasion. Acta Biochim Biophys Sin (Shanghai).
42:224–229. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Han Y, Liu Y, Nie L, Gui Y and Cai Z:
Inducing cell proliferation inhibition, apoptosis, and motility
reduction by silencing long non-coding ribonucleic acid
metastasis-associated lung adenocarcinoma transcript 1 in
urothelial carcinoma of the bladder. Urology. 81:209.e201–207.
2013. View Article : Google Scholar
|
|
33
|
Wang J, Wang H, Zhang Y, Zhen N, Zhang L,
Qiao Y, Weng W, Liu X, Ma L, Xiao W, et al: Mutual inhibition
between YAP and SRSF1 maintains long non-coding RNA, Malat1-induced
tumourigenesis in liver cancer. Cell Signal. 26:1048–1059. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Gutschner T and Diederichs S: The
hallmarks of cancer: A long non-coding RNA point of view. RNA Biol.
9:703–719. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Nakagawa S, Naganuma T, Shioi G and Hirose
T: Paraspeckles are subpopulation-specific nuclear bodies that are
not essential in mice. J Cell Biol. 193:31–39. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Nakagawa S, Ip JY, Shioi G, Tripathi V,
Zong X, Hirose T and Prasanth KV: Malat1 is not an essential
component of nuclear speckles in mice. RNA. 18:1487–1499. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Eissmann M, Gutschner T, Hämmerle M,
Günther S, Caudron-Herger M, Gross M, Schirmacher P, Rippe K, Braun
T, Zörnig M, et al: Loss of the abundant nuclear non-coding RNA
MALAT1 is compatible with life and development. RNA Biol.
9:1076–1087. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhang B, Arun G, Mao YS, Lazar Z, Hung G,
Bhattacharjee G, Xiao X, Booth CJ, Wu J, Zhang C, et al: The lncRNA
Malat1 is dispensable for mouse development but its transcription
plays a cis-regulatory role in the adult. Cell Rep. 2:111–123.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yan C, Chen J and Chen N: Long non-coding
RNA MALAT1 promotes hepatic steatosis and insulin resistance by
increasing nuclear SREBP-1c protein stability. Sci Rep.
6:226402016. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Park EJ, Lee JH, Yu GY, He G, Ali SR,
Holzer RG, Osterreicher CH, Takahashi H and Karin M: Dietary and
genetic obesity promote liver inflammation and tumorigenesis by
enhancing IL-6 and TNF expression. Cell. 140:197–208. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Schwarzer A, Wolf B, Fisher JL, Schwaab T,
Olek S, Baron U, Tomlinson CR, Seigne JD, Crosby NA, Gui J, et al:
Regulatory T-cells and associated pathways in metastatic renal cell
carcinoma (mRCC) patients undergoing DC-vaccination and
cytokine-therapy. PLoS One. 7:e466002012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Li Z, Tuteja G, Schug J and Kaestner KH:
Foxa1 and Foxa2 are essential for sexual dimorphism in liver
cancer. Cell. 148:72–83. 2012. View Article : Google Scholar : PubMed/NCBI
|
